Login
← Go Back
Nectar Lifesciences
NECLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Sanjiv Goyal · MD: Sanjiv Goyal · Listing date: July 19, 2005 · Employees: 1693 · Chandigarh · http://www.neclife.com
Stock Price vs Company Growth
1d
0.4%
1w
14.5%
1m
12.2%
3m
19.3%
6m
10.6%
1y
46.2%
5y
8.8%
10y
10.6%
all
1.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 12.3 0.4%
9.2
15.1
Company Overview
Sales
717 Cr
Growth: -16.1%
Profit after Tax
-361 Cr
Growth: 101.0%
Micro Cap
239 Cr
P/S: 0.3x
Industry P/S: 2.4x
Fundamentals
Sales (Cr) ₹ 717
Growth -16.1%
EBITDA -30.2%
P/S 0.3x
Dividend 0.0%
P/E -1.4x
Book Value ₹ 1.15
PEG Ratio 0.1x
ROE -1611.9%
P/B N/A
Shareholding Pattern
Institutions
Nsr Direct Pe Mauritius Llc
14.59 %
Ingain Traders, Llc
1.34 %
Iepf
0.02 %
Promoters
Sanjiv Goyal
31.33 %
Sanjiv (Huf)
24.47 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company has developed fully integrated sustainable production systems to manufacture high quality Cephalosporin intermediates, - Active Pharmaceuticals ingredients (APIs) and Finished Dosage Formulations (FDF or Formulations) to meet the diverse requirements of its customer base in India and over many countries worldwide.
Belongs to (4 Indices)
Investors (30)
religare...
sanjiv.g...
general....
Followers (2)
bhaskar6
sanjayda...